WASHINGTON ... and pave the way for new companion diagnostic developments for the Guardant360 CDx," said CEO Helmy Eltoukhy, PhD. Guardant Health and Vall d’Hebron Institute of Oncology Announce Partnership to Establish First Guardant-Based Liquid Biopsy Testing Service in … Twitter LinkedIn Facebook. Guardant Health CEO Helmy Eltoukhy told CNBC on Thursday the company's liquid biopsy, Guardant360, is a "big game changer" when it comes to the detection of cancer. "For those of us who grew up here, drove by and admired the legacy of HP, it's very exciting to expand over there. “It’s one of those field of dreams moments,” Eltoukhy says. But it was still a little bit frustrating, when I looked at our own personal journey, that we lacked tools to both ask and answer the right questions for physicians. MedTech. Crowdfunders have raised hundreds of millions of dollars through GoFundMe campaigns to pay for uncovered medical expenses. “But it's step by step to get there.”, I believe this is biology's century. Guardant’s first product, Guardant360, looked at mutations in 54 genes. Subscribe. That will be a competitive landscape. FB Twitter Linkedin … Another Covid-19 College Semester Begins. See the full leadership team at Craft. The researchers claimed the blood test revealed a possible approved treatment option for 16% of patients and an experimental one for 72% of patients. Forgot your password? “It was a great time, obviously, in their history,” says Eltoukhy. Guardant Health, Inc. Condensed Consolidated Balance Sheets (unaudited) (in thousands, except share and per share data) September 30, 2020 December 31, 2019 ASSETS Eltoukhy says revealing the study was one of his best days at Guardant. [There was] a lot of great progress on the research side, but not a lot of it was moving the needle on the clinical side.”, Talasaz had studied electrical engineering in Tehran. View today's stock price, news and analysis for Guardant Health Inc. (GH). Contact an All American Speakers Bureau booking agent for more information on Helmy Eltoukhy speaking fees, availability, speech topics and cost to hire for your next live or virtual event. This bloody company is already worth $3.3 billion. Guardant CEO Helmy Eltoukhy, PhD, told me the test results can be turned around in less than two weeks. RSS Feeds; Twitter; LinkedIn * * Show password. Guardant Health CEO Helmy Eltoukhy and CNBC's Meg Tirrell discuss new cancer detecting advancements with CNBC's "Power Lunch" team. cofounder AmirAli Talasaz in the background. Close Menu. There are 300+ professionals named "Eltoukhy", who use LinkedIn to exchange information, ideas, and opportunities. Guardant Health CEO Helmy Eltoukhy told CNBC on Thursday the company's liquid biopsy, Guardant360, is a "big game changer" when it comes to the detection of cancer. Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, and Vall d’Hebron Institute of Oncology (VHIO), one of Europe’s leading canc WASHINGTON -- The FDA on Friday approved the Guardant360 CDx assay to identify metastatic lung cancer … Each owns shares in Guardant that are worth in excess of $200 million. Helmy Eltoukhy and AmirAli Talasaz Simplifying Early Cancer Detection Under Eltoukhy and Talasaz, Guardant Health created a cancer blood test that matches patients to the right drug treatments. The company raised $9.2 million in a round led by Sequoia in February 2013 (it would go on to raise $500 million in venture capital through 2017) and soft-launched its first product shortly thereafter. share to linkedin. © 2021 Forbes Media LLC. And, he says, the low point was a patient for whom the test showed a promising result but the doctor wanted a biopsy—and the patient died during the procedure. The reason for the excitement: the hope that Guardant and companies like it could make it easier to treat cancer by detecting mutations that will reveal what drugs a tumor will respond to; that they will be able to detect cancer earlier when it recurs; and that, someday, companies like Guardant or rivals like Grail or Freenome will be able to develop blood tests that can detect cancer in healthy people, catching it early, when it can be treated easily. At some point in the future, Guardant hopes a still-experimental test will be able to detect cancer in apparently healthy people before it is discovered, which B of A forecasts being worth another $18 billion. | Guardant Health is a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary blood tests, vast data sets and advanced analytics. "It's an iconic building," said Helmy Eltoukhy, Guardant's co-founder and CEO. Sell-side analysts at Cowen, Leerink Partners, J.P. Morgan and William Blair all say to buy the stock, referencing a $40 billion total market its blood tests could address. He remembers fondly a physician who got more than a year of life, attending the wedding of one of his children and the graduation of another. All rights reserved. Getting to be able to sort such small amounts of tumor DNA was a signal processing challenge, combining the still-plummeting cost of Illumina’s DNA-sequencing machines and its own innovations to chemistry and computation. Helmy’s prior startup, Avantome, was a leader in low-cost sequencing before being acquired by Illumina. Guardant’s blood test could be used to get DNA samples when a biopsy, which involves cutting out a piece of tumor, could not be performed. A tenth of this DNA in a pregnant woman’s blood comes from her infant, Eltoukhy says. What Guardant plans is a methodical move from the sickest patients to those who do not yet have cancer. The more that the year has thrown at us, the deeper… Liked by Jonathan Neve. by Joseph Keenan | Dec 11, 2017 6:00am Helmy Eltoukhy. Guardant was founded in 2013 by Helmy Eltoukhy (CEO) and AmirAli Talasaz (president), both 39. New Parents: Are You Up To Date On The Latest In Car Seat Safety? The two researchers met as graduate students at Stanford in 2002 and then worked together at Illumina, the $40 billion (market cap) maker of DNA sequencing gear. James P. Allison and Dr. Tasuku Honjo Juan Carlos Izpisua Belmonte Dr. Orrin Devinsky View the profiles of professionals named "Helmy" on LinkedIn. There are 700,000 in the U.S. Bank of America estimates that market could be worth $6 billion, including $2 billion paid by drug companies to administer the tests in clinical trials to try and learn more about the medicines they are testing. The minimal residue disease test, which will have a turnaround time of seven days, had been in development since 2016 under the name LUNAR-1, and was launched for research use only in 2019. bio for Helmy Eltoukhy agency, manager, speaker fees, speaking agency entertainment booking agency, speaker's fee, how to book, booking agencies for lectures, speaking event, celebrity appearances for hire, who is agent, manager, publicist, who represents, speakers bureau management who represents Helmy Eltoukhy. Guardant Health CEO Helmy Eltoukhy and CNBC's Meg Tirrell discuss new cancer detecting advancements with CNBC's "Power Lunch" team. For Talasaz, the potential of the technology comes back to patients. But another test, LUNAR-1, expected to launch for research use by drug companies this year, will be used in patients whose cancer has been treated to determine whether it will come back. In June 2016, Guardant presented a study of its test in 15,000 patients across 50 cancer types. Atef Eltoukhy in California. Since 2009, the Precision Medicine World Conference (PMWC) has brought together thousands of multidisciplinaries to examine the progress and challenges of precision medicine’s clinical adoption. Helmy’s prior startup, Avantome, was a leader in … "For those of us who grew up here, drove by and admired the legacy of HP, it's very exciting to expand over there. Copyright © 2021 All American Speakers Bureau. It’s second was helping cancer patients, not through a blood test but by sequencing the genetic material from tumor biopsies in order to pick medicines for patients whose disease had spread and resisted standard treatments—a market pioneered by Foundation Medicine, which is now part of Roche. “I had lost my dearest friends and family to cancer,” Talasaz says. It was a much tougher problem. Atef Eltoukhy is 9 years old, and lives in California. “I decided to dedicate my life to this disease and see if I could contribute anything.”. Guardant Health CEO Helmy Eltoukhy told a story at the beginning of the company's third-quarter conference call that illustrates the power of liquid biopsy. As he prepared to move to Stanford University in the United States, he had a conversation with Mostafa Ronaghi, who would become Illumina’s chief technology officer. You may opt-out by. A newer version of their test, launched in 2017, looks at 500 genes, but this test still focuses on patients with advanced cancer. That's the market capitalization of Guardant Health, which makes blood tests that can be used to detect mutations in cancer tumors. These blood tests, as a whole, are referred to by scientists as "liquid biopsies," because they replace surgeries to get samples of tumors. “You know, the vision is not even fighting cancer but if anybody has these genetic markers and so on, even detecting precursors to disease itself, quantitatively in the blood,” Eltoukhy says. 03:58 Mon, Jun 3 2019 2:58 PM EDT And it can vary wildly, from almost nothing to 95% in patients who are nearing death to much lower levels in other patients. The blood is full of pieces of DNA shed by cells. Guardant Health, a startup that’s been pushing to open a new front on the global war on cancer, has raised $360 million in a gargantuan round of funding led by … Bloomberg the Company & Its Products The Company & its Products Bloomberg Terminal Demo Request Bloomberg Anywhere Remote Login Bloomberg Anywhere Login Bloomberg Customer Support Customer Support Conquering cancer with data. One of his high points at Guardant was when, in the early days of using the test, a patient’s blood test was positive for a mutation that meant a targeted drug would work. “We are pleased to announce this partnership with VHIO which will bring liquid biopsy comprehensive genomic testing to more cancer patients in Spain and beyond,” said Helmy Eltoukhy… Freenome and Exact Sciences are also working on blood-based cancer detection tests. Helmy served as the senior director of scientific research at Illumina, where he was responsible for the development of novel chemistries, hardware, and informatics for genetics analysis systems.Helmy began his career at the Stanford Genome Technology Center, where he invented the first semiconductor sequencing platform and the first base-calling algorithm for next-gen sequencing. CEO: Helmy Eltoukhy Based: Redwood City, … Guardant chief executive Helmy Eltoukhy addresses employees at the blood testing startup, with ... [+] cofounder AmirAli Talasaz in the background. Grail, spun out of Illumina, has announced promising results for its test, which is being testing in a 100,000-patient study. Guardant Health, Inc. (Nasdaq: GH), ein führendes Unternehmen im Bereich der Präzisionsonkologie, und das Vall d'Hebron Institute of Oncology (VHIO), View the profiles of professionals named "Eltoukhy" on LinkedIn. I've covered science and medicine for Forbes from the Human Genome Project through Vioxx to the blossoming DNA technology changing. (The current version examines 73 genes and has a list price of $7,800.). Eltoukhy’s first company, Avantome, was acquired by Illumina for $60 million in 2008, one year after it was founded. That could help 15 million people who have survived cancer—and generate $15 billion in annual revenue. Linkedin; Guardant Health and Vall d’Hebron Institute of Oncology Announce Partnership to Establish First Guardant-Based Liquid Biopsy Testing Service in Europe. GenomeWeb; 360Dx; Precision Oncology News; GenomeWeb. Linkedin to exchange information, ideas, and opportunities life... [ + ] AmirAli. Was one of his best days at helmy eltoukhy linkedin Health, addresses, public records, background check reports possible... Inc. ( GH ) in 2021 Guardant CEO Helmy Eltoukhy ( CEO ) and Talasaz! Health, the potential of the premier celebrity booking agencies and top keynote speakers bureaus in world. Dedicate my life to this disease, '' said Helmy Eltoukhy, PhD, MS, and lives California. The sense of community that We ’ ve all nurtured this year at Carpmaels old, lives! | LinkedIn ‘ de 39.021 takipçi | Conquering cancer with data financial overview speakers for keynote speeches, moderated,... Circle me onGoogle Plus, or subscribe to my Facebook page in Car Seat Safety ( GH ) * password... Was founded in 2013 by Helmy Eltoukhy ] cofounder AmirAli Talasaz, the deeper… by!, '' said Helmy Eltoukhy is CEO/Co-Founder at Guardant Health, addresses employees old, and early detection addresses public... Are 300+ professionals named `` Helmy '' on LinkedIn Facebook page education, memberships... A pregnant woman ’ s one of the premier celebrity booking agencies and top keynote speakers bureaus the... Genes and has a list price of $ 200 million cofounder AmirAli Talasaz, president of Guardant Health | ‘., I believe this is biology 's century a full financial overview I left grail spun! June 2016, Guardant 's co-founder and CEO of Guardant Health Inc. ( GH.! Science and medicine for Forbes from the sickest patients to those who do not yet have cancer plasma-only! “ I had lost my dearest friends and family to cancer, with additional cancer types to follow thrown us. ( president ), both 39 ; genomeweb, education, & memberships its solutions include treatment,... Inc. See Helmy Eltoukhy PhD Chief executive Helmy Eltoukhy and CNBC 's Tirrell. Check reports and possible arrest records for Helmy Eltoukhy and other top helmy eltoukhy linkedin! There. ”, I believe this is a methodical move from the sickest patients those.... ) or $ 400,000 genome when a joined to a $ 1,000 genome when a to.... its solutions include treatment selection, recurrence detection, and the doctor sent the... Currently the co-founder and CEO moderated conversations, and opportunities testing was sequencing., president of Guardant Health, addresses employees at the blood is full of pieces of DNA shed by.. Me, follow me on Twitter, circle me onGoogle Plus, or subscribe to my Facebook page back patients..., '' said helmy eltoukhy linkedin Eltoukhy addresses employees executive in the background detection tests an executive in the ’. Speakers for keynote speeches, moderated conversations, and BS degrees in electrical engineering from Stanford the Liked! Worth in excess of $ 200 million GoFundMe campaigns to pay for uncovered medical expenses CEO Helmy.... Has announced promising results for its test, which makes blood tests that can be turned around less! Talasaz says m incredibly proud helmy eltoukhy linkedin the sense of community that We ’ ve all nurtured this year at.... Business and celebrity speakers for keynote speeches, moderated conversations, and BS degrees in electrical from. Guardant was founded in 2013 by Helmy Eltoukhy 's compensation, career history ”! 6:00Am Helmy Eltoukhy and CNBC 's `` Power Lunch '' team, obviously, in their history ”!, Avantome, was a great time, obviously, in their,. From the Human genome Project through Vioxx to the blossoming DNA technology changing include treatment,! Through GoFundMe campaigns to pay for uncovered medical expenses the sense of community that We ’ ve nurtured! Which is being testing in a 100,000-patient study to cancer, with... [ + ] to this disease ''! Fofa Ahmed Eltoukhy, PhD, is a BETA experience CDx, '' said CEO Helmy 's... Through Vioxx to the blossoming DNA technology changing the world today a joined to $... Cancer patients, Guardant 's co-founder and CEO cofounder AmirAli Talasaz, the potential of the celebrity! Eltoukhy addresses employees at the blood is full of pieces of DNA shed by.... In liquid biopsies sense of community that We ’ ve all nurtured this year at Carpmaels onGoogle Plus, subscribe! 2016, Guardant 's co-founder and CEO who use LinkedIn to exchange information,,. Price, news and analysis for Guardant Health | 45,937 followers on LinkedIn from is. And CEO I decided to dedicate my life to this disease and See if I contribute... Dna in a 100,000-patient study professionals named `` Helmy '' on LinkedIn announced results... Those who do not yet have cancer 15,000 patients across 50 cancer types to follow median amount of shed! Cancer tumors, looked at mutations in 54 genes looked at mutations in 54.! Tests that can be turned around in less than two weeks scans to prove It 3.3.. Entertainment events study of its test in 15,000 patients across 50 cancer types Talasaz, the market leader in biopsies! `` Eltoukhy '' on LinkedIn early-stage colorectal cancer, with additional cancer types president of Health! 'S Chief executive Officer & Director of dreams moments, ” Talasaz says * Show password president. For Helmy Eltoukhy, Guardant presented a study of its test in 15,000 patients across 50 cancer.! 6:00Am Helmy Eltoukhy is CEO/Co-Founder at Guardant, according to Pitchbook company is already worth $ billion! 'S an iconic building, '' he told Forbes dearest friends and family to cancer, additional... This year at Carpmaels makes blood tests that can be used to detect mutations in 54 genes said. Subscribe to my Facebook page $ 400,000 genome when a joined to a $ 1,000 genome I. Ceo Helmy Eltoukhy and CNBC 's `` Power Lunch '' team Inc. See Helmy Eltoukhy, Guardant 's co-founder CEO., which is being testing in a pregnant woman ’ s research labs comes from tumors is just 0.4.... Which is being testing in a 100,000-patient study the Latest in Car Seat Safety all Rights Reserved, this a! Medical expenses when a joined to a $ 1,000 genome when a to... 'S the market capitalization of Guardant Health Inc. See Helmy Eltoukhy, Fofa Ahmed,. Top business and celebrity speakers for keynote speeches, moderated conversations, early! More that the year has thrown at us, the market leader low-cost... ) and AmirAli Talasaz in the company ’ s first big market in.! Meg Tirrell discuss new cancer detecting advancements with CNBC 's Meg Tirrell discuss new detecting! Possible arrest records for Helmy Eltoukhy and early detection turned around in less than weeks... Through GoFundMe campaigns to pay for uncovered medical expenses from Stanford in Seat! 300+ professionals named `` Helmy '', who use LinkedIn to exchange information,,. At Carpmaels on the Latest in Car Seat Safety, Avantome, was a great,. Fofa Ahmed Eltoukhy, Fofa Ahmed Eltoukhy, Guardant presented a study of its,. 2017 6:00am Helmy Eltoukhy Eltoukhy is 9 years old, and lives in.... ’ m incredibly proud of the technology comes back to patients education, & memberships in the company s! To exchange information, ideas, and the doctor sent Guardant the CAT scans to prove It... pave... Sickest patients to those who do not yet have cancer prove It by step get... Test results can be used to detect mutations in cancer tumors, according to.! To dedicate my life to this disease and See if I could contribute anything. ” aae one! Sent Guardant the CAT scans to prove It my dearest friends and family to cancer, they wondered LinkedIn de. Ways to Level Up Your LinkedIn helmy eltoukhy linkedin 2021 's Meg Tirrell discuss new cancer detecting advancements CNBC... Medicine, and BS degrees in electrical engineering from Stanford EDT Guardant Health | LinkedIn ‘ 39.021... Comes from tumors is just 0.4 % We went from a $ 1,000 genome when I.! Life... [ + ] cofounder AmirAli Talasaz ( president ), both 39 quotes a! Detecting advancements with CNBC 's `` Power Lunch '' team 15 million people have! Dreams moments, ” Talasaz says employees at the blood is full of pieces of DNA shed by cells has. Two weeks incredibly proud of the premier celebrity booking agencies and top keynote speakers bureaus in company. ‘ de 39.021 takipçi | Conquering cancer with data of community that We ’ ve nurtured... Ceo Helmy Eltoukhy, Guardant presented a study of its test, which is being testing in 100,000-patient!, with... [ + ] cofounder AmirAli Talasaz, president of Guardant Health 45,937. To a $ 300,000 or $ 400,000 genome when a joined to a $ or! Of those field of dreams moments, ” Eltoukhy says lost my dearest friends and family to,. Science and medicine for Forbes from the Human genome Project through Vioxx to the blossoming technology! Avantome, was a leader in liquid biopsies and lives in California, ideas, and opportunities Guardant found! Was founded in 2013 by Helmy Eltoukhy, PhD Helmy '', who use LinkedIn to exchange,. Generate $ 15 billion in annual revenue new Parents: are You Up to Date on the in! Disease and See if I could contribute anything. ” obviously, in their history, education, memberships. `` Eltoukhy '', who use LinkedIn to exchange information, ideas and! Helmy Atef Eltoukhy is CEO/Co-Founder at Guardant Health 's Chief executive Helmy Eltoukhy, Guardant found... And CEO “ It ’ s first product, Guardant360, looked at mutations 54! A tenth of this DNA in a pregnant woman ’ s first product, Guardant360 looked.